SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,930,553 | -40.4% | 9,240,887 | +5.7% | 0.74% | -30.1% |
| Q2 2023 | $58,563,943 | +2.9% | 8,740,887 | 0.0% | 1.06% | -5.0% |
| Q1 2023 | $56,903,174 | -23.7% | 8,740,887 | 0.0% | 1.12% | -21.7% |
| Q4 2022 | $74,559,766 | +61.6% | 8,740,887 | 0.0% | 1.43% | +66.4% |
| Q3 2022 | $46,152,000 | +24.5% | 8,740,887 | 0.0% | 0.86% | +27.5% |
| Q2 2022 | $37,061,000 | +20.8% | 8,740,887 | 0.0% | 0.67% | +35.2% |
| Q1 2022 | $30,681,000 | -47.3% | 8,740,887 | 0.0% | 0.50% | -33.6% |
| Q4 2021 | $58,214,000 | -33.3% | 8,740,887 | 0.0% | 0.75% | -22.0% |
| Q3 2021 | $87,234,000 | -67.7% | 8,740,887 | 0.0% | 0.96% | -64.9% |
| Q2 2021 | $270,006,000 | -29.2% | 8,740,887 | 0.0% | 2.73% | -23.4% |
| Q1 2021 | $381,365,000 | -5.8% | 8,740,887 | 0.0% | 3.57% | +0.6% |
| Q4 2020 | $405,053,000 | – | 8,740,887 | – | 3.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |